Celecoxib and bevacizumab synergistically inhibit non-small cell lung cancer by inducing apoptosis and modulating VEGF and MMP-9 expression Page No: 501-506

By: Abdul Qadir, Zurqa Khalid, Fareha Kashan Theba, Muhammad Mujtaba Ali, Mahayrookh Asif, Fatima Rizvi

Keywords: Bevacizumab, celecoxib, non-small cell lung cancer

DOI : 10.36721/PJPS. 2023.36.2.REG.501-506.1

Abstract: Lung cancer is the most typical form of cancer that results in death worldwide

[View Complete Article]